✦ LIBER ✦

A Randomized, Double-Blind, Phase III Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non–Small-Cell Lung Cancer After Disease Progression After 1 Previous Platinum-Based Therapy (REVEL): Treatment Rationale and Study Design

✍ Scribed by Edward B. Garon; Dachuang Cao; Ekaterine Alexandris; William J. John; Sergey Yurasov; Maurice Perol

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ramucirumab plus docetaxel versus placeb

✍ Garon, Edward B (author);Ciuleanu, Tudor-Eliade (author);Arrieta, Oscar (author) 📂 Article 📅 2014 🏛 Elsevier BV 🌐 English ⚖ 389 KB

Treatment, Rationale, and Study Design o

✍ Cesare Gridelli; Antonio Rossi; Paola Venturino; Filippo de Marinis 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 101 KB

Treatment Rationale Study Design for the

✍ David R. Spigel; Martin J. Edelman; Tony Mok; Kenneth O'Byrne; Luis Paz-Ares; We 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 255 KB

Treatment Rationale and Study Design for

✍ Jyoti D. Patel; Philip Bonomi; Mark A. Socinski; Ramaswamy Govindan; Shengyan Ho 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 100 KB